PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-0.12%
Negative net income growth while MRVL stands at 3.37%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
-0.97%
Negative yoy D&A while MRVL is 4.53%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
185.19%
Some yoy growth while MRVL is negative at -69430.00%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
-3.23%
Both cut yoy SBC, with MRVL at -11.88%. Martin Whitman would view it as an industry shift to reduce stock-based pay or a sign of reduced expansions.
49.40%
Slight usage while MRVL is negative at -954.91%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
430.95%
AR growth well above MRVL's 136.91%. Michael Burry would fear inflated sales or less stringent credit controls vs. competitor.
-371.43%
Negative yoy inventory while MRVL is 171.44%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
162.50%
A yoy AP increase while MRVL is negative at -299.18%. John Neff would see competitor possibly improving relationships or liquidity more rapidly.
-82.87%
Both reduce yoy usage, with MRVL at -218.55%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
-517.39%
Negative yoy while MRVL is 31.96%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
-8.03%
Both yoy CFO lines are negative, with MRVL at -43.29%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
-21.36%
Negative yoy CapEx while MRVL is 17.67%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
21.36%
Less M&A spending yoy vs. MRVL's 663.54%, reducing near-term risk. David Dodd would confirm the firm is not missing out on a strategic deal that competitor might exploit.
-33.10%
Negative yoy purchasing while MRVL stands at 33.66%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
15.29%
We have some liquidation growth while MRVL is negative at -56.89%. John Neff notes a short-term liquidity advantage if competitor is holding or restricted.
68.13%
We have some outflow growth while MRVL is negative at -94.92%. John Neff sees competitor possibly pulling back more aggressively from minor expansions or intangible invests.
-28.20%
Both yoy lines negative, with MRVL at -106.93%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
No Data
No Data available this quarter, please select a different quarter.
105.88%
Issuance growth of 105.88% while MRVL is zero at 0.00%. Bruce Berkowitz sees a mild dilution that must be justified by expansions or acquisitions vs. competitor’s stable share base.
-4.18%
We cut yoy buybacks while MRVL is 99.35%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.